Perbedaan Greenwood Sejahtera Tbk. dan Tempo Scan Pacific Tbk.: Greenwood Sejahtera Tbk. diperdagangkan di Rp119 (kapitalisasi pasar 920,49 M, volume 24 jam 1,58 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 12,1× kapitalisasi pasar Greenwood Sejahtera Tbk., dan Greenwood Sejahtera Tbk. lebih aktif diperdagangkan (1,58 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.
| GWSA | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 920,49 M | 11,18 T |
Volume | 1,58 jt | 613 rb |
Lot | 15,83 rb | 6,13 rb |
Perputaran | 190,42 jt | 1,54 M |
Harga Rata-rata | 120,33 | 2.511,52 |
Nilai Transaksi | 190,42 jt | 1,54 M |
Harga Ekuilibrium Indikatif | 119 | 2.520 |
Volume Ekuilibrium Indikatif | 936 | 17 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Greenwood Sejahtera is part of KG Global Development. On the begining, the company have a relation with Jababeka group, which own the land that has been used to builit TCC Batavia.PT Greenwood Sejahtera, company that developing The City Center Batavia (TCC Batavia), on December 23, 2011. The City Center Batavia is a superblock, mix used development project on top of 2,1 hectares of land. Its first tower is a skycrapper building: a tower with 46 storey, plus an 8 storey annex. According to the masterplan, Greenwood Sejahtera will build 3 tower on the site. The other tower will be completed in 2017 and the area will be expanded to 5.4 hectares. Its ground breaking ceremony is on September 12, 2009.
Selengkapnya di halaman GWSA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →